AQR Arbitrage’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

AQR Arbitrage’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-274,853	Closed	-$36.2M	–	1554
2020 Q4	$36.2M	Buy	+274,853	New	+$24.3M	1.27%	4

AQR Arbitrage's EIDX Position: Q1 2021 in Review

AQR Arbitrage sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 274,853 shares — an estimated $36.2M sold.

AQR Arbitrage first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $36.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

AQR Arbitrage reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 274,853 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $36.2M.
AQR Arbitrage first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Eidos Therapeutics, Inc. Common Stock position peaked at $36.2M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.